MSB 5.24% $1.11 mesoblast limited

Ann: Mesoblast Webcast, page-183

  1. 6,428 Posts.
    lightbulb Created with Sketch. 2617
    I guess when you don't pay for the study you are at the mercy of the sponsor.
    It was a free hit but even a free hit needs to be given a proper chance. Of course, it wasn't a free hit when it came to MSB internal resources. However, if the Novartis deal works out it will have been worth it, otherwise not.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.